J0163 — Injection, epinephrine in sodium chloride (endo), 0.1 mg
J0163 is a HCPCS Level II code for injection, epinephrine in sodium chloride (endo), 0.1 mg. It belongs to the Drugs Administered Other Than Oral Method section. Whether Medicare pays it depends on the coverage rule below.
Medicare coverage: Special coverage instructions apply
There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
Physician fee schedule statusE
Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).
Global period: XXX
Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.
The CMS record for J0163
- Long descriptor
- Injection, epinephrine in sodium chloride (endo), 0.1 mg
- Short descriptor
- Epinephrine in nacl (endo)
- Added
- October 1, 2025
- BETOS
- O1E
- Pricing indicator
- 51 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Drugs.
Codes adjacent to J0163
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J0163 is not quite right, the correct code is very often within a few positions of it.
- J0136Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg
- J0137Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg
- J0138Injection, acetaminophen 10 mg and ibuprofen 3 mg
- J0139Injection, adalimumab, 1 mg
- J0150Injection, adenosine for therapeutic use, 6 mg (not to be used to report any adenosine phosphate compounds, instead use a9270)terminated
- J0151Injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270)terminated
- J0153Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)
- J0162Injection, epinephrine (fresenius), not therapeutically equivalent to j0165, 0.1 mg
- J0164Injection, epinephrine in sodium chloride (baxter), 0.1 mg
- J0165Injection, epinephrine, not otherwise specified, 0.1 mg
- J0166Injection, epinephrine (bpi), not therapeutically equivalent to j0165, 0.1 mg
- J0167Injection, epinephrine (hospira), not therapeutically equivalent to j0165, 0.1 mg
- J0168Injection, epinephrine (international medication systems), not therapeutically equivalent to j0165, 0.1 mg
- J0169Injection, epinephrine (adrenalin), not therapeutically equivalent to j0165, 0.1 mg
- J0171Injection, adrenalin, epinephrine, 0.1 mgterminated
- J0172Injection, aducanumab-avwa, 2 mgterminated
Questions about J0163
What is HCPCS code J0163?
J0163 is a HCPCS Level II code for injection, epinephrine in sodium chloride (endo), 0.1 mg. It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J0163?
The CMS HCPCS file marks J0163 as "Special coverage instructions apply". There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
How is J0163 paid under the physician fee schedule?
J0163 carries PFS status code E. Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).